KENDALL JENSON: Open Payments
NPI 1881706885 · SCOTTSDALE, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$11,529 in 259 payments from 22 companies in 2025. Trend: 2023 $8,779 · 2024 $11,641 · 2025 $11,529
Consulting: $6,950Food & beverage: $4,469Education: $110
| Company | Payments | Amount |
|---|---|---|
| PFIZER INC. | 12 | $2,421 |
| Journey Medical Corporation | 2 | $1,766 |
| Galderma Laboratories, L.P. | 19 | $1,145 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 17 | $1,091 |
| Ortho Dermatologics, a division of Bausch Health US, LLC | 5 | $1,008 |
| Amgen Inc. | 17 | $944 |
| ABBVIE INC. | 35 | $459 |
| Incyte Corporation | 15 | $455 |
| Janssen Biotech, Inc. | 20 | $335 |
| Novartis Pharmaceuticals Corporation | 16 | $334 |
Products named: CIBINQO, NEMLUVIO, Cabtreo, OTEZLA, Winlevi, OPZELURA, DUPIXENT, TREMFYA.
Industry payments across AZ — which companies pay providers there.
